Core Insights - Clorox Company has a market capitalization of $12.5 billion and is recognized for its diverse range of household cleaning and lifestyle products [1] - The company is classified as a large-cap stock, reflecting its significant market presence and leadership in the household and personal care sector [2] Financial Performance - Clorox shares have declined 29.8% from their 52-week high of $150.84 reached in April 2025, but have gained 8.7% over the past three months, outperforming the Nasdaq Composite's 6.9% decline [3] - Over the past six months, Clorox is down 12.1%, while the Nasdaq Composite has only declined by 2.8% [5] - In the last 52 weeks, Clorox has fallen 26.9%, significantly underperforming the Nasdaq Composite, which has increased by 23.4% during the same period [5] Market Challenges - The decline in Clorox's stock is attributed to weaker-than-expected earnings, driven by reduced demand for cleaning products and consumers opting for cheaper alternatives amid economic uncertainty [6] - The company has faced disruptions from its ERP system transition and lingering supply chain issues, which have negatively impacted shipments and market share recovery [6] - Increased manufacturing and logistics costs, along with heightened competition, have pressured profit margins and affected investor sentiment [6] Competitive Landscape - Clorox has underperformed compared to its rival, Procter & Gamble, which has seen a decline of 13.6% over the past 52 weeks and 5.6% over the past six months [7]

Core Viewpoint - Clorox's 4.07% dividend yield is attractive but faces challenges due to operational turbulence and margin pressure, raising questions about sustainability in the face of potential risks ahead [1][2] Dividend Performance - Clorox paid $1.24 per share on February 13, 2026, marking 48 consecutive years of dividend increases, with a total dividend payout of $602 million for fiscal 2025 [1] - The company generated $981 million in operating cash flow, resulting in a 61.4% payout ratio, indicating adequate coverage of the dividend [1] - Free cash flow for fiscal 2025 was $761 million, providing 1.26x coverage after capital expenditures, a recovery from fiscal 2024's 0.81x coverage [1][2] - The dividend has grown 33.8% from $450 million in fiscal 2018 to $602 million in fiscal 2025, with a compound annual growth rate of approximately 5.2% [1] Yield Context - Clorox's 4.07% yield is significantly higher than Procter & Gamble's 2.63% and Kimberly-Clark's 4.76%, reflecting investor skepticism about Clorox's near-term prospects [1] - The stock has seen a year-to-date gain of 26.21% as of February 12, 2026, but is down 11.86% over the past year and 20.32% over five years, indicating a depressed stock price of $125.82 [1] Operational Challenges - Clorox's gross margin has compressed to 43.2% due to consumers opting for cheaper alternatives, with management projecting only flat to 1% organic growth for the latter half of fiscal 2026 [1] - The company's profit margin of 11.2% and operating margin of 14.1% are below those of Procter & Gamble, highlighting an efficiency disadvantage [1] Strategic Moves - Clorox's $2.25 billion acquisition of GOJO Industries aims to strengthen its health and hygiene portfolio but introduces integration risks during a challenging operational period [1] - The company faces a $14.15 million fine from the Consumer Product Safety Commission for delayed warnings about bacterial contamination in Pine-Sol products, involving 37 million bottles recalled [1] Future Outlook - Management has reaffirmed fiscal 2026 adjusted earnings guidance of $5.95 to $6.30 per share, projecting gross margin expansion in the latter half of the year [1] - The upcoming CAGNY Conference on February 19, 2026, will be critical for investors to assess guidance for fiscal 2027 and the timeline for margin recovery [2]

Core Insights - The Clorox Company, based in Oakland, California, has a market capitalization of $14.5 billion and is known for its well-established brands such as Clorox, Pine-Sol, Glad, Burt's Bees, and Hidden Valley [1] Performance Overview - Over the past 52 weeks, Clorox shares have declined by 18.1%, underperforming the S&P 500 Index, which increased by 15.6%. However, year-to-date (YTD), Clorox stock is up 19.5%, outperforming the S&P 500's 1.7% return [2] - Clorox has also underperformed the State Street Consumer Staples Select Sector SPDR ETF (XLP), which rose by 9.1% over the past 52 weeks, but has outpaced XLP's 12.2% YTD increase [3] Earnings Report - On February 3, Clorox shares rose by 1.5% following a mixed Q2 earnings release. The company's revenue slightly decreased year-over-year to $1.7 billion but exceeded Wall Street expectations by 2.5%. Adjusted EPS fell by 10.3% from the previous year to $1.39, missing analyst expectations of $1.43 [4] Future Earnings Expectations - For the current fiscal year ending in June, analysts project Clorox's EPS to decline by 23.3% year-over-year to $5.92. The company's earnings surprise history is mixed, with two out of the last four quarters exceeding consensus estimates and two missing [5] Analyst Ratings - Among 18 analysts covering Clorox, the consensus rating is a "Hold," consisting of one "Strong Buy," 13 "Hold," and four "Strong Sell" ratings [5] - Morgan Stanley analyst Dara Mohsenian maintained a "Hold" rating on Clorox with a price target of $136, indicating a potential upside of 12% from current levels. The company is currently trading above its mean price target of $116.27, while the highest price target of $151 suggests a potential upside of 24.3% [7]

Core Viewpoint - The article discusses consumer stocks that are positioned for significant stock recovery and continued dividend growth, emphasizing the importance of dividend investing over growth investing [1][2]. Clorox - Clorox is known for its bleach and owns other brands like Pine-Sol and Burt's Bees, benefiting from increased cleanliness demand during the COVID-19 pandemic [3]. - The stock has lost about 50% of its value over the last five years due to inflation, a cyberattack, and ERP software transition challenges [3]. - Clorox's current market cap is $13 billion, with a stock price of $109.98 and a dividend yield of 4.47%, supported by a consistent annual payout increase for 49 years [4][5]. - The investment in ERP software is expected to enhance efficiency, and the stock's P/E ratio of 17 suggests potential for dividend growth and stock price recovery [6]. Target - Target operates approximately 2,000 stores across the U.S. and has faced challenges such as rising inventories and falling sales post-pandemic [7][8]. - The stock has started to recover from its November low, with a current price of $111.14 and a dividend yield of 4.06%, marking it as a Dividend King with 54 years of payout increases [10]. - Target's P/E ratio is 13, significantly lower than competitors like Walmart and Costco, which trade at 42 and 51 times earnings, respectively, indicating potential for stock price recovery alongside rising dividends [11].

Core Viewpoint - Clorox's dividend yield appears attractive at just under 5%, but the stock has declined 37% over the past year, raising concerns about the sustainability of the dividend [1][9]. Dividend Metrics - The annual dividend is $4.92 per share, resulting in a dividend yield of 4.99% [2]. - Clorox has increased its dividend for over 13 consecutive years, with the most recent increase being 1.6% in April 2025 [2]. - The 5-year compound annual growth rate (CAGR) for dividends is 2.5% [2]. Cash Flow Analysis - In fiscal 2025, Clorox paid $602 million in dividends against a free cash flow of $761 million, resulting in a free cash flow payout ratio of 79% [3][4]. - The payout ratio was concerning in fiscal 2024, where dividends exceeded free cash flow at 123% [3][4]. - Operating cash flow has shown volatility, with figures swinging from $1.5 billion in fiscal 2020 to $695 million in fiscal 2024, then recovering to $981 million in fiscal 2025 [4]. Debt and Equity Position - Clorox has a total debt of $2.88 billion and cash reserves of $167 million, leading to a net debt of $2.71 billion [5]. - The net debt-to-EBITDA ratio is 2.4x, which is considered manageable for a consumer staples company [5]. - Shareholder equity has decreased significantly from $908 million in fiscal 2020 to $321 million in fiscal 2025, indicating a trend of paying out more in dividends and buybacks than the company has earned [6]. Management Outlook - CEO Linda Rendle acknowledged near-term challenges but highlighted operational strength, noting a tenth consecutive quarter of gross margin expansion [7]. - CFO Luc Bellet mentioned expected tariff headwinds of about $100 million annually but views this as manageable through sourcing changes and targeted pricing [7]. - Management expressed confidence in the balance sheet and cash flow, suggesting the dividend is secure, although dividend growth has slowed to 1.6% in 2025 compared to historical rates of 5% to 7% [8]. Dividend Safety Assessment - Clorox has a moderate risk rating for dividend safety, with a fiscal 2025 payout ratio of 79% deemed technically sustainable [9]. - However, the previous year's payout ratio of 123% and recent cash flow volatility raise concerns about the dividend's sustainability [9][10].

Core Viewpoint - Clorox's stock has declined 37% over the past year, raising concerns about the sustainability of its attractive dividend yield of 4.99% [2] Financial Metrics - Clorox pays an annual dividend of $4.92 per share, with a dividend yield of 4.99% and has increased dividends for over 13 consecutive years, with a recent increase of 1.6% in April 2025 [2] - The company reported free cash flow of $761 million in fiscal 2025, an improvement from $483 million in fiscal 2024, while dividends paid remained stable at $602 million [4] - The free cash flow payout ratio improved from 123% in fiscal 2024 to 79% in fiscal 2025, indicating a more manageable dividend payout [3][4] Cash Flow and Debt Analysis - Operating cash flow has been volatile, decreasing from $1.5 billion in fiscal 2020 to $695 million in fiscal 2024, then recovering to $981 million in fiscal 2025 [4] - Clorox has total debt of $2.88 billion against $167 million in cash, resulting in net debt of $2.71 billion, with a net debt-to-EBITDA ratio of 2.4x, which is considered manageable for a consumer staples company [5][6] Shareholder Equity and Management Outlook - Shareholder equity has declined significantly from $908 million in fiscal 2020 to $321 million in fiscal 2025, reflecting a history of paying out more in dividends and buybacks than the company earned [6][7] - Management acknowledges near-term challenges but remains confident in operational strength, citing a 10th consecutive quarter of gross margin expansion and plans to manage expected annual tariff headwinds of $100 million through sourcing changes and targeted pricing [8]

Group 1: Investment Opportunities in Packaged Goods - Investment in packaged goods stocks, such as Procter & Gamble and Kimberly-Clark, is suggested as they are seen as undervalued winners in the sector [1][2] - The packaged goods sector has faced challenges due to high inflation and low growth, but inflation may be nearing its peak, potentially reducing costs for consumer giants [2] - Kimberly-Clark's acquisition of Kenvue is noted, along with praise for its brands, while Procter & Gamble is recognized for its innovation and scale to lower product costs [3] Group 2: Broader Market Insights - Clorox is highlighted as a poor performer in the S&P 500, but its products, including Burt's Bees and Hidden Valley, are still favored [3] - General Mills is mentioned as a risky investment, particularly if there is speculation about a takeover, due to the impact of weight loss drugs on food stocks [3] - Beyond traditional packaged goods, opportunities in pharmaceuticals are emphasized, with Johnson & Johnson and Amgen identified as solid picks amid expected industry mergers [4]

Core Insights - The article discusses consumer stocks with high-yielding dividends and a history of payout increases, highlighting the balance between dividend yield and associated risks [1][2]. Group 1: Realty Income - Realty Income is known as the "monthly dividend company," owning over 15,600 single-tenant, net-leased properties, allowing it to avoid income tax on operational income by distributing over 90% of net income as dividends [3][4]. - The company has consistently increased its monthly dividend since 1994, currently offering an annual dividend of over $3.23 per share, translating to a cash return of over 5.3% [4][8]. - Realty Income faced challenges during the pandemic and rising interest rates, leading to a stock price discount of approximately 24% from its early 2020 high [5][6]. - With declining interest rates, Realty Income is positioned to reduce costs and expand, trading at about 15 times its funds from operations (FFO) income of $4.11 per share [7][8]. Group 2: Clorox - Clorox, known for its cleaning products, experienced a surge in demand during the pandemic but has since faced a decline in stock price, trading at about a 50% discount from its all-time high [9][11]. - The company has been impacted by a cyberattack in 2023, disrupting its supply chain and leading to product shortages [10][11]. - Despite these challenges, Clorox maintains a history of dividend increases, currently offering an annual payout of $4.96 per share, resulting in a dividend yield of over 4.1% [13][14]. - Clorox's price-to-earnings ratio is 18, below the S&P 500 average of 31, making it attractive for dividend investors seeking potential stock-price appreciation [13][14][15].